Christopher B. Begley - May 12, 2023 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role: Director
Signature: /s/ Matthew R. St. Louis, Attorney-in-Fact for Christopher B. Begley (power of attorney previously filed)
Stock symbol: ZBH
Transactions as of: May 12, 2023
Transactions value $: $0
Form type: 4
Date filed: 5/16/2023, 04:13 PM
Previous filing: Apr 4, 2023
Next filing: Jul 5, 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZBH	Phantom Stock Units	Award	$0	+500	+3.01%	$0.00	17.1K	May 12, 2023	Common Stock	500	$136.73	Direct	F1, F2, F3, F4
transaction	ZBH	Restricted Stock Units	Award	$0	+951	+8.15%	$0.00	12.6K	May 12, 2023	Common Stock	951		Direct	F2, F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.
F2	The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3	These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
F4	Includes 28.223 phantom stock units accrued on April 28, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F5	The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
F6	Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.